31 Oct, 2011: Equity Buy/Sell (Technical View) IFCI research,

Please Share:: India Equity Research Reports, IPO and Stock News
Visit http://indiaer.blogspot.com/ for complete details �� ��

Equity Buy/Sell (Technical View)

Ø  Along with Nifty, many frontline scrips have gained further strength.

Ø  The following (already recommended at various points of time) can be accumulated :

o   ACC > 1245 ;                      Alok Ind. > 21/50 ;                  DLF > 253 ;                        Dr. Reddy > 1690 ;

o   Ambuja Cem > 163 ;          ICICI > 940 ;                            ITC > 218 ;                         Kotak Bk. > 523 ;

o   M&M > 881 ;                      Omaxe > 148 ;                       Tata Steel > 493.

Ø  The following are for the short term :

o   Aban > 434 ;                      Auro Pharma > 131 ;       Ansal Prop. > 37/40 ;              Ashok Leyland > 27/30 ;

o   BEML > 533 ;                     Century Text. > 331 ;      Federal Bk. > 417 ;                  JSW Steel > 675 ;

o   GMR Infra > 28/50 ;          HDIL > 101 ;                    IDBI > 116 ;                             IVRCL Infra > 41/50 ;

o   JP Associates > 80/50 ;     Polaris > 150 ;                Praj Ind. > 86 ;                         RIIL > 426/50 ;

o   Puravankara > 80/50 ;       R Com > 82/50 ;             Rel Energy > 483/50 ;             SAIL > 118.

CURRENCY : USD VS INR

Ø  As we had mentioned earlier, Rupee has reacted (strengthened) and has touched 48/61. It has supports at 48, 47/50 from where it could reverse direction and weaken again.

Have strict stop losses